trending Market Intelligence /marketintelligence/en/news-insights/trending/PC1p73NzwpHc91X1-0iihg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Genebiotech Q1 profit climbs YOY


So, the data lakehouse is now officially a ‘thing’ – what is it and why should you care?


Industry Top Trends 2021: Oil and Gas


Charter, DIRECTV and Comcast rank as the top 'RSN-friendly' MVPDs

Industry Top Trends 2021: Metals and Mining

Genebiotech Q1 profit climbs YOY

Genebiotech Co. Ltd. said its first-quarter normalized net income amounted to 36.81 South Korean won per share, a gain from 17.66 won per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 266.5 million won, a gain from 119.9 million won in the prior-year period.

The normalized profit margin increased to 2.4% from 1.0% in the year-earlier period.

Total revenue declined 5.2% year over year to 11.30 billion won from 11.92 billion won, and total operating expenses decreased 6.7% from the prior-year period to 11.31 billion won from 12.12 billion won.

Reported net income totaled 166.4 million won, or 22.99 won per share, compared to a loss of 54.7 million won, or a loss of 8.06 won per share, in the year-earlier period.

As of May 14, US$1 was equivalent to 1,090.69 South Korean won.